Word

A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH

Status

Registered

Status Code

700

Status Date

Tuesday, July 12, 2022

Serial Number

90809062

Registration Number

6791631

Registration Date

Tuesday, July 12, 2022

Mark Type

4000

Filing Date

Friday, July 2, 2021

Trademark Owner History

ELIM Holdings, LLC - Original Registrant

Classifications

42 Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors; Research and development in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors.; Scientific research for medical purposes in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors

Trademark Events

Sep 15, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Sep 15, 2023

Teas Change Of Correspondence Received

Sep 15, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Sep 15, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 12, 2022

Notice Of Registration Confirmation Emailed

Jul 12, 2022

Registered-Supplemental Register

Jun 6, 2022

Law Office Publication Review Completed

Jun 2, 2022

Assigned To Lie

May 27, 2022

Assigned To Lie

May 20, 2022

Approved For Registration Supplemental Register

May 18, 2022

Examiner's Amendment Entered

May 18, 2022

Notification Of Examiners Amendment E-Mailed

May 18, 2022

Examiners Amendment E-Mailed

May 18, 2022

Examiners Amendment -Written

Apr 20, 2022

Teas/Email Correspondence Entered

Apr 20, 2022

Correspondence Received In Law Office

Apr 20, 2022

Teas Response To Office Action Received

Nov 19, 2021

Notification Of Non-Final Action E-Mailed

Nov 19, 2021

Non-Final Action E-Mailed

Nov 19, 2021

Non-Final Action Written

Nov 2, 2021

Assigned To Examiner

Sep 14, 2021

New Application Office Supplied Data Entered

Jul 6, 2021

New Application Entered